Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Pain 6Neoplasms 3Neoplasm Metastasis 2Cancer Pain 2Breast Neoplasms 2Wounds and Injuries 1Pleural Effusion, Malignant 1Pain, Postoperative 1Mucositis 1Lung Neoplasms 1Leiomyoma 1Ileus 1Head and Neck Neoplasms 1Agnosia 1

Interventions

Oxaliplatin 67Capecitabine 60Fluorouracil 58Bevacizumab 54Gemcitabine 51Paclitaxel 50Leucovorin 50Irinotecan 40Docetaxel 39Carboplatin 39Cisplatin 38pembrolizumab 37Nivolumab 37Cetuximab 35Sunitinib 25Trastuzumab 24Radiosurgery 24Radiotherapy 21Doxorubicin 21Cyclophosphamide 21Panitumumab 20Drug Therapy 19Pemetrexed 18Everolimus 18Sorafenib 17Interleukin-2 16Fulvestrant 16Albumin-Bound Paclitaxel 16atezolizumab 15Erlotinib Hydrochloride 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Neoplasm Metastasis × Morphine × Clear all
NCT00712712 2025-08-29

MEDOR

Institut Bergonié

Phase 2 Completed
78 enrolled 28 charts

Neoplasm Metastasis, Pain

NCT00644319 2009-07-08

Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion

National Cancer Institute (NCI)

Phase 2 Unknown
320 enrolled
Thoracic

Neoplasm Metastasis, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡